Estrogens, Esterified (USP): Clinical Trials

3 terminated, 2 completed. 5 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	5	Terminated 3, Completed 2

Follow Estrogens, Esterified (USP): new trials by email Literature Review of Estrogens, Esterified (USP) trials Research Report on Estrogens, Esterified (USP)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes Esterified Estrogens (EE) and Methyltestosterone (MT) - Hot Flushes, Menopause, Postmenopause	Phase 2	Completed	Solvay Pharmaceuticals	1251	2005-06-01	2008-08-15
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women esterified estrogens 1.25mg and methyltestosterone 2.5mg, Esterified estrogens 1.25 mg - Menopause	Phase 2	Terminated	Solvay Pharmaceuticals	133	2004-07-01	2008-04-11
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women esterified estrogens 1.25 mg and methyltestosterone 2.5 mg, Esterified estrogens 1.25 mg - Menopause	Phase 2	Terminated	Solvay Pharmaceuticals	28	2004-07-01	2008-04-11
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women esterified estrogens 0.625 mg and methyltestosterone 1.25 mg - Menopause	Phase 2	Completed	Solvay Pharmaceuticals	350	2004-06-01	2015-01-16
High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy esterified estrogens - Breast Cancer	Phase 2	Terminated	Northwestern University	1	2004-03-01	2012-06-11

Conditions studied

Breast Neoplasms (1)  ·  Hot Flashes (1)

Sponsors

Solvay Pharmaceuticals (4)  ·  Northwestern University (1)

Countries

United States (5)  ·  Canada (1)  ·  Russia (1)

Top investigators

William J. Gradishar, MD (1)

NIH funding

2005 (1)